Their results are, however, not directly comparable to our own since they used lines with varying degrees of baseline UPS function, including several from patients with known Alzheimer’s disease, examined neurons at later stages of development, and focused exclusively on heavy molecular weight phosphorylated tau rather than total tau expression. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.